Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs

• Status: Recruiting
• Trial end date: 2022-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to look at how Alpha-1-antitrypsin (AAT) deficiency and Cystic Fibrosis (CF) affect white blood cells in the lungs, called macrophages, and their ability to work.

• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Florida
• Treatments: Albuterol; Alpha 1-Antitrypsin

Criteria

Inclusion Criteria:

• Signed informed consent

• Male or female 18 years of age or older

• Negative pregnancy test for women of childbearing potential

• Hemoglobin >12.5 g/dl measured on the day of participation

• Negative urine nicotine test

Exclusion Criteria:

• Pregnancy or breastfeeding

• Weight < 50 kg

• History of anemia requiring blood transfusions, erythropoietin supplementation, or iron supplementation within the past 36 months

• Known hemoglobin <12.5 g/dl within the past 90 days

• Systolic blood pressure > 180 mmHg and/or diastolic blood pressure >100 mmHg

• Poor venous access

• Large volume blood donation (>200 ml or 7 ounces) within the previous 56 days (e.g. blood donation for the purposes of blood banking)

• Clinically significant cardiac, hemostatic or neurological impairment or any other significant medical condition that, in the opinion of the investigator would affect subject safety (e.g., recent myocardial infarction, history of prolonged bleeding time, cerebral vascular accident, advanced cancer or uncontrolled medical condition)

• Psychiatric or cognitive disturbance or illness that would affect subject safety

• Current smoker